
Anne L Maitland MD PhD
Asthma & Allergic Conditions, Clinical & Laboratory Immunology
Medical Director, Center for Ehlers-Danlos Care at the Medical University of South Carolina Associate Professor, Department of Medicine at the Medical University of South Carolina - Division of Rheumatology Consultant Allergy / immunology - Clinical Paradigms
Join to view full profile
22 Westedge St. Suite 300Charleston, SC 29403
Phone+1 212-241-6500
Dr. Maitland is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My career has always been fueled by a deep curiosity about the immune system and the ways its dysregulation can give rise to disease. I first encountered the broad spectrum of immune dysfunction in the 1980s, as I witnessed the HIV and asthma epidemics unfold in my hometown of New York City.
Today, Long COVID stands as a striking example of acquired neuroimmune dysregulation, affecting an estimated 7% of the U.S. population. It joins a broader constellation of conditions—ranging from chronic fatigue syndromes triggered by infectious or toxic insults to emerging evidence of neurodevelopmental challenges and heightened environmental sensitivities—particularly in individuals with connective tissue disorders like Ehlers-Danlos Syndromes (EDS). For those with hypermobile EDS (hEDS) and Hypermobility Spectrum Disorders (HSD), the absence of clear diagnostic markers for associated conditions such as dysautonomia and Mast Cell Activation Syndrome often leads to years of unrecognized neuroimmune dysfunction and microscopic tissue injury.
In collaboration with Drs. Chip Norris, Cortney Gensemer, and Sunil Patel, the Ehlers-Danlos Syndrome Institute (EDSI) at the Medical University of South Carolina aspires to be a beacon of innovation in the care of complex, multisystem disorders. Our vision is to provide integrative, patient-centered solutions for those navigating this intricate axis of neuroimmune dysregulation—cutting through the fragmentation of traditional, siloed healthcare.
Selected Heritable Disorders of Connective Tissue, https://nap.nationalacademies.org/download/26431
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Allergy and Immunology, 2000 - 2002
Brigham and Women's HospitalFellowship, Allergy and Immunology, 1999 - 2000
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
University of PennsylvaniaPhD, 1989 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1997
Certifications & Licensure
MD State Medical License 2020 - 2027
NY State Medical License 2000 - 2027
SC State Medical License 2025 - 2027
UT State Medical License 2023 - 2026
NJ State Medical License 2002 - 2007
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2012, 2014, 2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Publications & Presentations
PubMed
- 1 citationsLetter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehlers-Danlos Syndrome?Caitlin Green, Anne Maitland, Steven A Kautz, Russell Norris, Sunil Patel
Alimentary Pharmacology & Therapeutics. 2025-06-01 - 18 citationsMast cell activation syndrome: Current understanding and research needs.Mariana Castells, Matthew P Giannetti, Matthew J Hamilton, Peter Novak, Olga Pozdnyakova
The Journal of Allergy and Clinical Immunology. 2024-08-01 - 32 citationsAssociation of mast-cell-related conditions with hypermobile syndromes: a review of the literature.Ashley Monaco, Diane Choi, Serife Uzun, Anne Maitland, Bernadette Riley
Immunologic Research. 2022-08-01
Journal Articles
- Mast Cell Disorders in Ehlers Danlos SyndromeSuranjith L Seneviratne, Anne Maitland, Lawrence Afrin, American Journal of Medical Genetics, 1/1/2017
- State of Asthma Education in Urban Residency ProgramsKuryan, J. and A. Maitland, J Allergy Clinical Immunology, 1/1/2009
- A case of profound relapse of atopic disease in the setting of idiopathic CD4 lymphopeniaAgarwal, S and A. Maitland, Annals Allergy Asthma Immunology, 1/1/2009
Books/Book Chapters
Authored Content
- Misdiagnoses Happen. Medical Gaslighting Should NotMarch 2020
- Munchausen or Missed Diagnosis?March 2020
Press Mentions
Targeted Approaches to Systemic Mastocytosis ManagementSeptember 3rd, 2024
Conference Speaker: Dr. Anne Maitland, MD, PhD—Integrative Therapy for Mast Cell Activation DisorderJune 28th, 2022
7th East-West Integrative Medical Symposium for Immunology & WellnessJuly 7th, 2021
Professional Memberships
- Member
- American College of Allergy, Asthma, & ImmunologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:












